Showing results (2201-2210 of 4,522) with videos related to

Sort By:
Pageof 453
Advances in Therapy|August 25, 2026
Physician and Patient Perception of Disease, Symptomatology, and Treatment Administration Preference in Paroxysmal Nocturnal Haemoglobinuria: Results from a Real-World SurveyBing Han, Maria-Magdalena Balp, Josefin Snellman, et al.
Advances in Therapy|August 20, 2026
BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US PhysiciansRahul Banerjee, Hamza Hashmi, Preet M Chaudhary, et al.
Advances in Therapy|August 14, 2026
Pharmacokinetics, Safety, and Immunogenicity of DMB-3115, a Ustekinumab Biosimilar for Immune-Mediated Diseases, in Healthy Japanese Male Participants: A Randomized, Double-Blind, Single-Dose StudyHironori Konishi, Takeyuki Shindo, Michio Yagi, et al.
Advances in Therapy|September 15, 2026
Evinacumab Across Different Lipid Phenotypes: A Systematic Review and Meta-AnalysisWalter Masson, Martín Lobo, Mara Mansur, et al.
Advances in Therapy|December 14, 2022
Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World SettingCharles Lynde, Elisabeth Riedl, Julia-Tatjana Maul, et al.
Advances in Therapy|June 29, 2022
Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in ChinaCongling Gu, Hui Huang, Yi Han
Advances in Therapy|June 30, 2022
Triplet RVd Induction for Transplant-Eligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-AnalysisGuangzhong Yang, Chuanying Geng, Yuan Jian, et al.
Advances in Therapy|November 23, 2022
Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)Lauren C Powell, Gilbert L'Italien, Evan Popoff, et al.
Advances in Therapy|November 24, 2022
Levothyroxine Bioequivalence Study and Its Narrow Therapeutic Index: Comparative Bioavailability Results Between Two Formulations Available in Latin AmericaCarlos Walter Bertoncini, Maria Juliana Cruz Palacios, María Carolina Fritz, et al.
Advances in Therapy|December 11, 2022
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or AcromegalyDermot O'Toole, Pamela L Kunz, Susan M Webb, et al.
Pageof 453